Flagship R&D Facility Opens in New Jersey

2 min read
Marking an $800 million investment, the property can be expanded to 1 million square feet. The post Flagship R&D Facility Opens in New Jersey appeared first on Commercial Property Executive.
BeiGene’s flagship facility houses biologics manufacturing activities and a clinical research and development center. Image by Frank H. Conlon, courtesy of BeiGene Ltd.

Global oncology company BeiGene Ltd. has opened its flagship U.S. facility in Hopewell, N.J., an approximately 400,000-square-foot building at the Princeton West Innovation Campus. The property has room for expansion to 1 million square feet.

The $800 million investment marks the completion of the firm’s three-year initiative to broaden its integrated manufacturing and R&D operations across the country. By the end of 2025, BeiGene aims to create hundreds of new jobs at the new site.

The firm purchased the Hopewell property from Lincoln Equities Group in November 2021 and broke ground on the project in April 2022. DPR Construction served as construction manager, while IPS-Integrated Project Services provided architectural and engineering services.

READ ALSO: Life Science Prospects Are Looking Up

Carrying the address 311 Pennington Rocky Hill Road, the facility houses biologics manufacturing activities and a clinical research and development center. The 42-acre property features multiple sustainable components, including a heating and cooling system that uses recycled wastewater, the site also being solar-ready.

The building is part of Princeton West Innovation Campus, a 433-acre complex that was acquired in 2020 by Lincoln Equities and H.I.G. The 1.2 million-square-foot master plan comprises office, R&D and data center space, with room for future developments.

New Jersey’s booming life science sector

New Jersey stands out as one of the premier life science hubs in the U.S., attracting top companies in the sector. The metro comprises more than 22 million square feet of lab space, which is expected to grow by 27 percent by 2026, according to a Choose New Jersey report.

SJP Properties and New Brunswick Development Corp. are currently working on a $731 million life science project that will encompass almost 1.2 million square feet across two buildings. Dubbed HELIX Health + Life Science Exchange, the innovation district will house the New Jersey Innovation HUB and Rutgers Robert Wood Johnson Medical School.

The post Flagship R&D Facility Opens in New Jersey appeared first on Commercial Property Executive.

Leave a Reply

Your email address will not be published. Required fields are marked *